IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.322
+0.005 (1.42%)
At close: Nov 20, 2024, 4:00 PM
0.346
+0.024 (7.62%)
Pre-market: Nov 21, 2024, 6:00 AM EST
IN8bio Market Cap
IN8bio has a market cap or net worth of $23.30 million as of November 21, 2024. Its market cap has decreased by -30.43% in one year.
Market Cap
23.30M
Enterprise Value
24.77M
1-Year Change
-30.43%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $23.30M, a decrease of -87.57%. That is a compound annual growth rate of -46.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 23.30M | -60.95% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioXcel Therapeutics | 23.96M |
| Ocean Biomedical | 23.91M |
| Tempest Therapeutics | 23.87M |
| PolyPid | 23.74M |
| Chemomab Therapeutics | 23.55M |
| Acurx Pharmaceuticals | 22.58M |
| NeuroOne Medical Technologies | 22.46M |
| AEON Biopharma | 22.27M |